News

A study shows physician counseling boosts safe adherence and curbs misinformation-driven decisions, as pregnant women often stop skin treatments and experience worsened symptoms.

The upcoming trial will assess an injectable formulation of Xvie, distinct from its currently available topical counterpart.

Overall, the future of dermatology lies in integrating innovation with individualized, evidence-based, and patient-centered care.

IL-17 inhibitors are highly effective, but many patients still require switching due to treatment failure, loss of response, or intolerance.

Successful negotiation integrates compensation, productivity, procedural access, and autonomy to create a sustainable, well-valued clinical role.

PANP360 Immersive will deliver one-day, high-yield dermatology CME for NPs and PAs, featuring hands-on workshops, complex case strategies, and practical tips to optimize therapies.

In a striking finding, 97% of patients who had experienced no facial repigmentation whatsoever at week 24 demonstrated measurable F-VASI improvement after 104 weeks of continuous ruxolitinib cream use.

Twin experts reveal how dermatology and dentistry team up for facial aesthetics, early lesion detection, and safer care—from lasers to oral screenings.

Phase 2 APEX part A data showed zumilokibart maintained EASI-75 responses in 75–85% of week 16 responders at 1 year across quarterly and biannual dosing regimens.

Swanson and Silverberg explain why tween skin care trends harm barriers, and how clinicians can simplify routines and spot allergens.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

In case you missed it, this week we had news on the FDA's approval of icotrokinra, phase 3 ADorable-1 data supporting lebrikizumab, the sBLA acceptance of tildrakizumab for PsA, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Panelists discuss the role of communication, follow-up, and safety monitoring in optimizing long-term biologic therapy outcomes.

Renata Block, DMSc, MMS, PA-C, and Jamie Restivo, MPAS, PA-C, explore how hypochlorous acid sprays and sodium hypochlorite washes simplify AD adjunct care, improving adherence, antimicrobial control, and symptom relief.

Only 15–20% of eligible patients currently receive systemic psoriasis treatment, and specialists believe icotrokinra's simplicity could meaningfully move that needle.

Susan C. Taylor, MD, moderated a recent Case-Based Roundtable discussion on topical treatment options for vitiligo.

Aging hair fibers become finer in diameter, increasing vulnerability to chemical and physical damage.

When used thoughtfully, Faranak Kamangar, MD, says AI can transform generic processes into innovative, time-saving clinical tools.

Clinician contract negotiation is often treated as administrative, but it directly affects pay, autonomy, workflow, and career trajectory.

Molecular NOS2/CCL27 testing outperforms standard biopsy reads for psoriasis versus eczema, reducing diagnostic uncertainty in CHE and speeding targeted treatment.

Omar Noor, MD, FAAD, discusses strategies to improve psoriasis care for patients facing adherence challenges related to lifestyle or cognitive barriers.

Trainees identified legal, ethical, and reliability concerns as key barriers to integrating AI into dermatology practice.

Defined by emotional exhaustion, depersonalization, and reduced accomplishment, burnout goes beyond a difficult day in clinic.

Clinical trial data showed approximately 70% of patients achieved clear or almost clear skin with icotrokinra by week 16.

This review of the latest dermatological studies includes insights on chronic hand eczema patch testing, case reporting, microbiome impact, and more.

New study links acne to higher serum amyloid A1 inflammation, while lipid shifts hint at systemic effects and new clues for scars and severity.

New data show that nearly 40% of eczema patients face insurance-related barriers, delaying or preventing access to prescribed therapies.

Discover how physician-led dermatology practices build patient-first culture, drive innovation, and sustain long-term care in a changing health care market.

Women often present with sudden skin, hair, and vascular changes that may signal perimenopause rather than normal aging.